Abiopharma

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

Ultragenyx Provides Financial and Business Updates at J.P. Morgan Annual Healthcare Conference

EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance

XOMA Royalty Announces CFO Transition

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference

Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44th Annual J.P. Morgan Healthcare Conference

NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue

OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance

CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results